Skip to content

Clinical trials

Phase 4 Autoimmune Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 4 Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20093
20101
20122
20132
20151
20161
20181
20206
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status5
Recruiting4
Terminated1
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Human Genome Sciences Inc., a GSK Company2
Medical University of Graz2
Assistance Publique - Hôpitaux de Paris1
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1
First Affiliated Hospital of Wenzhou Medical University1
Georgetown University1
Keio University1
Massachusetts General Hospital1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases26
Lupus Erythematosus, Systemic5
Diabetes Mellitus4
Arthritis, Rheumatoid2
Connective Tissue Diseases2
Diabetes Mellitus, Type 12
Glomerulonephritis2
Immune System Diseases2
Obsessive-Compulsive Disorder2
Anxiety Disorders1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.